
    
      After signing the informed consent and having met the inclusion criteria, patients will be
      randomized to 1 of the 3 arms and treated for a total duration of 5 days. Patients in all
      arms will receive chemotherapy beginning 4-24 hours after the first dose of rasburicase or
      allopurinol.
    
  